Chromoendoscopy versus autofluorescence imaging for neoplasia detection in patients with longstanding ulcerative colitis (FIND-UC): an international, multicentre, randomised controlled trial.

<h4>Background</h4> <p>Patients with longstanding ulcerative colitis (UC) undergo regular dysplasia surveillance because of increased colorectal cancer risk. Previous studies demonstrated that autofluorescence imaging (AFI) and chromoendoscopy (CE) increased dysplasia detection. T...

Full description

Bibliographic Details
Main Authors: Vleugels, JLA, Rutter, MD, Ragunath, K, Rees, CJ, Ponsioen, CY, Lahiff, C, Ket, SN, Wanders, LK, Samuel, S, Butt, F, Kuiper, T, Travis, SPL, D'Haens, G, Wang, LM, van Eeden, S, East, JE, Dekker, E
Format: Journal article
Language:English
Published: Elsevier 2018
_version_ 1797061761088618496
author Vleugels, JLA
Rutter, MD
Ragunath, K
Rees, CJ
Ponsioen, CY
Lahiff, C
Ket, SN
Wanders, LK
Samuel, S
Butt, F
Kuiper, T
Travis, SPL
D'Haens, G
Wang, LM
van Eeden, S
East, JE
Dekker, E
author_facet Vleugels, JLA
Rutter, MD
Ragunath, K
Rees, CJ
Ponsioen, CY
Lahiff, C
Ket, SN
Wanders, LK
Samuel, S
Butt, F
Kuiper, T
Travis, SPL
D'Haens, G
Wang, LM
van Eeden, S
East, JE
Dekker, E
author_sort Vleugels, JLA
collection OXFORD
description <h4>Background</h4> <p>Patients with longstanding ulcerative colitis (UC) undergo regular dysplasia surveillance because of increased colorectal cancer risk. Previous studies demonstrated that autofluorescence imaging (AFI) and chromoendoscopy (CE) increased dysplasia detection. The aim of this study was to determine whether AFI should be further studied as an alternative method for dysplasia surveillance in patients with longstanding UC.</p> <h4>Methods</h4> <p>In this prospective international, randomised trial, 210 patients undergoing colonoscopy surveillance for longstanding UC were randomised between 1 August 2013 and 10 March 2017 for inspection with either AFI or CE (105:105). Randomisation was minimised for a previous history of dysplasia and a previous history of primary sclerosing cholangitis. The main outcome was the relative dysplasia detection rate calculated by the ratio of AFI versus CE. This relative dysplasia detection rate was determined for the proportion of UC patients in which at least one dysplastic lesion was detected and for the mean number of dysplastic lesions per patient. The relative dysplasia detection rate needed to be above 0·67 for both outcomes to support performing a subsequent large non-inferiority trial, using an 80% confidence interval. Analysis was performed per protocol. The trial is registered at Netherlands Trial Register (NTR4062).</p> <h4>Findings</h4> <p>AFI detected dysplasia in 13 (12·4%) patients, compared to 20 patients (19·1%) with CE. The relative dysplasia detection rate of CE versus AFI for the proportion of UC patients with at least one dysplastic lesion was 0·65 (80% CI; 0·43-0·99). The mean number of detected dysplastic lesions per patient was 0·13 for AFI compared to 0·37 for CE (relative dysplasia detection rate 0·36, 80% CI; 0·21-0·61). Two patients experienced an adverse event (intraprocedural mild bleeding = 1, abdominal pain = 1) in the AFI-arm and three patients (intraprocedural mild bleeding = 2, perforation = 1) in the CE-arm.</p> <h4>Interpretation</h4> <p>In this randomised study comparing AFI with CE for dysplasia surveillance in patients with longstanding UC, AFI did not meet criteria for proceeding to a large non-inferiority trial. Therefore, current AFI technology should not be further investigated as an alternative dysplasia surveillance method.</p>
first_indexed 2024-03-06T20:35:53Z
format Journal article
id oxford-uuid:329b4127-ceb9-4a70-8dc7-02628afc6319
institution University of Oxford
language English
last_indexed 2024-03-06T20:35:53Z
publishDate 2018
publisher Elsevier
record_format dspace
spelling oxford-uuid:329b4127-ceb9-4a70-8dc7-02628afc63192022-03-26T13:15:15ZChromoendoscopy versus autofluorescence imaging for neoplasia detection in patients with longstanding ulcerative colitis (FIND-UC): an international, multicentre, randomised controlled trial.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:329b4127-ceb9-4a70-8dc7-02628afc6319EnglishSymplectic Elements at OxfordElsevier2018Vleugels, JLARutter, MDRagunath, KRees, CJPonsioen, CYLahiff, CKet, SNWanders, LKSamuel, SButt, FKuiper, TTravis, SPLD'Haens, GWang, LMvan Eeden, SEast, JEDekker, E <h4>Background</h4> <p>Patients with longstanding ulcerative colitis (UC) undergo regular dysplasia surveillance because of increased colorectal cancer risk. Previous studies demonstrated that autofluorescence imaging (AFI) and chromoendoscopy (CE) increased dysplasia detection. The aim of this study was to determine whether AFI should be further studied as an alternative method for dysplasia surveillance in patients with longstanding UC.</p> <h4>Methods</h4> <p>In this prospective international, randomised trial, 210 patients undergoing colonoscopy surveillance for longstanding UC were randomised between 1 August 2013 and 10 March 2017 for inspection with either AFI or CE (105:105). Randomisation was minimised for a previous history of dysplasia and a previous history of primary sclerosing cholangitis. The main outcome was the relative dysplasia detection rate calculated by the ratio of AFI versus CE. This relative dysplasia detection rate was determined for the proportion of UC patients in which at least one dysplastic lesion was detected and for the mean number of dysplastic lesions per patient. The relative dysplasia detection rate needed to be above 0·67 for both outcomes to support performing a subsequent large non-inferiority trial, using an 80% confidence interval. Analysis was performed per protocol. The trial is registered at Netherlands Trial Register (NTR4062).</p> <h4>Findings</h4> <p>AFI detected dysplasia in 13 (12·4%) patients, compared to 20 patients (19·1%) with CE. The relative dysplasia detection rate of CE versus AFI for the proportion of UC patients with at least one dysplastic lesion was 0·65 (80% CI; 0·43-0·99). The mean number of detected dysplastic lesions per patient was 0·13 for AFI compared to 0·37 for CE (relative dysplasia detection rate 0·36, 80% CI; 0·21-0·61). Two patients experienced an adverse event (intraprocedural mild bleeding = 1, abdominal pain = 1) in the AFI-arm and three patients (intraprocedural mild bleeding = 2, perforation = 1) in the CE-arm.</p> <h4>Interpretation</h4> <p>In this randomised study comparing AFI with CE for dysplasia surveillance in patients with longstanding UC, AFI did not meet criteria for proceeding to a large non-inferiority trial. Therefore, current AFI technology should not be further investigated as an alternative dysplasia surveillance method.</p>
spellingShingle Vleugels, JLA
Rutter, MD
Ragunath, K
Rees, CJ
Ponsioen, CY
Lahiff, C
Ket, SN
Wanders, LK
Samuel, S
Butt, F
Kuiper, T
Travis, SPL
D'Haens, G
Wang, LM
van Eeden, S
East, JE
Dekker, E
Chromoendoscopy versus autofluorescence imaging for neoplasia detection in patients with longstanding ulcerative colitis (FIND-UC): an international, multicentre, randomised controlled trial.
title Chromoendoscopy versus autofluorescence imaging for neoplasia detection in patients with longstanding ulcerative colitis (FIND-UC): an international, multicentre, randomised controlled trial.
title_full Chromoendoscopy versus autofluorescence imaging for neoplasia detection in patients with longstanding ulcerative colitis (FIND-UC): an international, multicentre, randomised controlled trial.
title_fullStr Chromoendoscopy versus autofluorescence imaging for neoplasia detection in patients with longstanding ulcerative colitis (FIND-UC): an international, multicentre, randomised controlled trial.
title_full_unstemmed Chromoendoscopy versus autofluorescence imaging for neoplasia detection in patients with longstanding ulcerative colitis (FIND-UC): an international, multicentre, randomised controlled trial.
title_short Chromoendoscopy versus autofluorescence imaging for neoplasia detection in patients with longstanding ulcerative colitis (FIND-UC): an international, multicentre, randomised controlled trial.
title_sort chromoendoscopy versus autofluorescence imaging for neoplasia detection in patients with longstanding ulcerative colitis find uc an international multicentre randomised controlled trial
work_keys_str_mv AT vleugelsjla chromoendoscopyversusautofluorescenceimagingforneoplasiadetectioninpatientswithlongstandingulcerativecolitisfinducaninternationalmulticentrerandomisedcontrolledtrial
AT ruttermd chromoendoscopyversusautofluorescenceimagingforneoplasiadetectioninpatientswithlongstandingulcerativecolitisfinducaninternationalmulticentrerandomisedcontrolledtrial
AT ragunathk chromoendoscopyversusautofluorescenceimagingforneoplasiadetectioninpatientswithlongstandingulcerativecolitisfinducaninternationalmulticentrerandomisedcontrolledtrial
AT reescj chromoendoscopyversusautofluorescenceimagingforneoplasiadetectioninpatientswithlongstandingulcerativecolitisfinducaninternationalmulticentrerandomisedcontrolledtrial
AT ponsioency chromoendoscopyversusautofluorescenceimagingforneoplasiadetectioninpatientswithlongstandingulcerativecolitisfinducaninternationalmulticentrerandomisedcontrolledtrial
AT lahiffc chromoendoscopyversusautofluorescenceimagingforneoplasiadetectioninpatientswithlongstandingulcerativecolitisfinducaninternationalmulticentrerandomisedcontrolledtrial
AT ketsn chromoendoscopyversusautofluorescenceimagingforneoplasiadetectioninpatientswithlongstandingulcerativecolitisfinducaninternationalmulticentrerandomisedcontrolledtrial
AT wanderslk chromoendoscopyversusautofluorescenceimagingforneoplasiadetectioninpatientswithlongstandingulcerativecolitisfinducaninternationalmulticentrerandomisedcontrolledtrial
AT samuels chromoendoscopyversusautofluorescenceimagingforneoplasiadetectioninpatientswithlongstandingulcerativecolitisfinducaninternationalmulticentrerandomisedcontrolledtrial
AT buttf chromoendoscopyversusautofluorescenceimagingforneoplasiadetectioninpatientswithlongstandingulcerativecolitisfinducaninternationalmulticentrerandomisedcontrolledtrial
AT kuipert chromoendoscopyversusautofluorescenceimagingforneoplasiadetectioninpatientswithlongstandingulcerativecolitisfinducaninternationalmulticentrerandomisedcontrolledtrial
AT travisspl chromoendoscopyversusautofluorescenceimagingforneoplasiadetectioninpatientswithlongstandingulcerativecolitisfinducaninternationalmulticentrerandomisedcontrolledtrial
AT dhaensg chromoendoscopyversusautofluorescenceimagingforneoplasiadetectioninpatientswithlongstandingulcerativecolitisfinducaninternationalmulticentrerandomisedcontrolledtrial
AT wanglm chromoendoscopyversusautofluorescenceimagingforneoplasiadetectioninpatientswithlongstandingulcerativecolitisfinducaninternationalmulticentrerandomisedcontrolledtrial
AT vaneedens chromoendoscopyversusautofluorescenceimagingforneoplasiadetectioninpatientswithlongstandingulcerativecolitisfinducaninternationalmulticentrerandomisedcontrolledtrial
AT eastje chromoendoscopyversusautofluorescenceimagingforneoplasiadetectioninpatientswithlongstandingulcerativecolitisfinducaninternationalmulticentrerandomisedcontrolledtrial
AT dekkere chromoendoscopyversusautofluorescenceimagingforneoplasiadetectioninpatientswithlongstandingulcerativecolitisfinducaninternationalmulticentrerandomisedcontrolledtrial